2018 Q2 Form 10-Q Financial Statement

#000114420418062664 Filed on November 30, 2018

View on sec.gov

Income Statement

Concept 2018 Q2 2017 Q2
Revenue $57.83M $52.23M
YoY Change 10.72% 50.93%
Cost Of Revenue $83.91M $34.81M
YoY Change 141.04% 44.36%
Gross Profit -$26.08M $17.42M
YoY Change -249.72% 66.05%
Gross Profit Margin -45.1% 33.35%
Selling, General & Admin $10.61M $3.399M
YoY Change 212.0% 44.82%
% of Gross Profit 19.51%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.810M $600.0K
YoY Change 201.67% 13.21%
% of Gross Profit 3.44%
Operating Expenses $11.35M $3.520M
YoY Change 222.33% 49.98%
Operating Profit -$37.43M $13.90M
YoY Change -369.27% 70.68%
Interest Expense $3.346M $61.00K
YoY Change 5385.25% -82.67%
% of Operating Profit 0.44%
Other Income/Expense, Net -$3.346M -$61.00K
YoY Change 5385.25% -82.67%
Pretax Income -$40.77M $13.84M
YoY Change -394.63% 77.61%
Income Tax -$10.16M $5.314M
% Of Pretax Income 38.4%
Net Earnings -$30.62M $8.525M
YoY Change -459.13% 76.5%
Net Earnings / Revenue -52.94% 16.32%
Basic Earnings Per Share -$0.72 $0.21
Diluted Earnings Per Share -$0.72 $0.20
COMMON SHARES
Basic Shares Outstanding 42.40M 41.57M
Diluted Shares Outstanding 42.40M 43.55M

Balance Sheet

Concept 2018 Q2 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.300M $33.70M
YoY Change -93.18% 2146.67%
Cash & Equivalents $2.334M $33.67M
Short-Term Investments
Other Short-Term Assets $3.100M $6.300M
YoY Change -50.79% 125.0%
Inventory $116.4M $64.60M
Prepaid Expenses
Receivables $37.94M $24.50M
Other Receivables $3.900M $0.00
Total Short-Term Assets $163.7M $129.1M
YoY Change 26.78% 53.69%
LONG-TERM ASSETS
Property, Plant & Equipment $29.16M $7.200M
YoY Change 305.04% 1.41%
Goodwill $47.80M
YoY Change
Intangibles $30.94M
YoY Change
Long-Term Investments
YoY Change
Other Assets $176.0K $2.100M
YoY Change -91.62% 5.0%
Total Long-Term Assets $117.3M $13.30M
YoY Change 782.2% -2.21%
TOTAL ASSETS
Total Short-Term Assets $163.7M $129.1M
Total Long-Term Assets $117.3M $13.30M
Total Assets $281.0M $142.4M
YoY Change 97.34% 45.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.80M $9.700M
YoY Change 11.34% 97.96%
Accrued Expenses $23.30M $3.600M
YoY Change 547.22% 16.13%
Deferred Revenue
YoY Change
Short-Term Debt $55.08M $0.00
YoY Change -100.0%
Long-Term Debt Due $1.050M $100.0K
YoY Change 950.0% -66.67%
Total Short-Term Liabilities $90.16M $15.60M
YoY Change 477.94% -56.18%
LONG-TERM LIABILITIES
Long-Term Debt $100.8M $100.0K
YoY Change 100742.0% -97.56%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $100.8M $100.0K
YoY Change 100742.0% -97.56%
TOTAL LIABILITIES
Total Short-Term Liabilities $90.16M $15.60M
Total Long-Term Liabilities $100.8M $100.0K
Total Liabilities $191.0M $15.70M
YoY Change 1116.56% -60.45%
SHAREHOLDERS EQUITY
Retained Earnings -$24.95M
YoY Change
Common Stock $424.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $90.01M $126.6M
YoY Change
Total Liabilities & Shareholders Equity $281.0M $142.4M
YoY Change 97.34% 45.9%

Cashflow Statement

Concept 2018 Q2 2017 Q2
OPERATING ACTIVITIES
Net Income -$30.62M $8.525M
YoY Change -459.13% 76.5%
Depreciation, Depletion And Amortization $1.810M $600.0K
YoY Change 201.67% 13.21%
Cash From Operating Activities -$770.0K -$6.230M
YoY Change -87.64% -496.82%
INVESTING ACTIVITIES
Capital Expenditures -$570.0K -$270.0K
YoY Change 111.11% -30.77%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$570.0K -$270.0K
YoY Change 111.11% -30.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.700M 20.00K
YoY Change 13400.0% -102.44%
NET CHANGE
Cash From Operating Activities -770.0K -6.230M
Cash From Investing Activities -570.0K -270.0K
Cash From Financing Activities 2.700M 20.00K
Net Change In Cash 1.360M -6.480M
YoY Change -120.99% -1900.0%
FREE CASH FLOW
Cash From Operating Activities -$770.0K -$6.230M
Capital Expenditures -$570.0K -$270.0K
Free Cash Flow -$200.0K -$5.960M
YoY Change -96.64% -404.08%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
37938000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5002000 USD
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2334000 USD
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14831000 USD
CY2018Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
55082000 USD
CY2017Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1050000 USD
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2018-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Registrant Name
EntityRegistrantName
HUDSON TECHNOLOGIES INC /NY
dei Entity Central Index Key
EntityCentralIndexKey
0000925528
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Trading Symbol
TradingSymbol
HDSN
CY2018Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
42599431 shares
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Small Business
EntitySmallBusiness
false
CY2017Q4 us-gaap Goodwill
Goodwill
49464000 USD
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30461000 USD
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29163000 USD
CY2017Q4 us-gaap Assets Current
AssetsCurrent
208916000 USD
CY2018Q2 us-gaap Assets Current
AssetsCurrent
163677000 USD
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6934000 USD
CY2018Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3119000 USD
CY2017Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
9664000 USD
CY2018Q2 us-gaap Income Tax Receivable
IncomeTaxReceivable
3838000 USD
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
114302000 USD
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
424000 USD
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
424000 USD
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q4 us-gaap Liabilities
Liabilities
197991000 USD
CY2018Q2 us-gaap Liabilities
Liabilities
191000000 USD
CY2017Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1473000 USD
CY2018Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
95360000 USD
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
90158000 USD
CY2017Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
65152000 USD
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
3520000 USD
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
11346000 USD
CY2017Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
121000 USD
CY2018Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
741000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Estimates and Risks</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires the use of estimates and assumptions that affect the amounts reported in these financial statements and footnotes. The Company considers these accounting estimates to be critical in the preparation of the accompanying consolidated financial statements. The Company uses information available at the time the estimates are made. However, these estimates could change materially if different information or assumptions were used. Additionally, these estimates may not ultimately reflect the actual amounts of the final transactions that occur.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company utilizes both internal and external sources to evaluate potential current and future liabilities for various commitments and contingencies. In the event that the assumptions or conditions change in the future, the estimates could differ from the original estimates.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.5in; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Several of the Company&#8217;s accounting policies involve significant judgments, uncertainties and estimates. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions. To the extent that actual results differ from management&#8217;s judgments and estimates, there could be a material adverse effect on the Company. On a continuous basis, the Company evaluates its estimates, including, but not limited to, those estimates related to its allowance for doubtful accounts, inventory reserves, valuation allowance for deferred tax assets, and commitments and contingencies. With respect to accounts receivable, the Company estimates the necessary allowance for doubtful accounts based on both historical and anticipated trends of payment history and the ability of the customer to fulfill its obligations. For inventory, the Company evaluates both current and anticipated sales prices of its products to determine if a write down of inventory to net realizable value is necessary. In determining the Company&#8217;s valuation allowance for its deferred tax assets, the Company assesses its ability to generate taxable income in the future.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company participates in an industry that is highly regulated, and changes in the regulations affecting its business could affect its operating results. Currently the Company purchases virgin hydrochlorofluorocarbon (&#8220;HCFC&#8221;) and hydrofluorocarbon (&#8220;HFC&#8221;) refrigerants and reclaimable, primarily HCFC, HFC and chlorofluorocarbon (&#8220;CFC&#8221;), refrigerants from suppliers and its customers. Effective January 1, 1996, the Clean Air Act (the &#8220;Act&#8221;) prohibited the production of virgin CFC refrigerants and limited the production of virgin HCFC refrigerants. Effective January 2004, the Act further limited the production of virgin HCFC refrigerants and federal regulations were enacted which established production and consumption allowances for HCFC refrigerants which imposed limitations on the importation of certain virgin HCFC refrigerants. Under the Act, production of certain virgin HCFC refrigerants is scheduled to be phased out during the period 2010 through 2020, and production of all virgin HCFC refrigerants is scheduled to be phased out by 2030. In October 2014, the EPA published a final rule providing further reductions in the production and consumption allowances for virgin HCFC refrigerants for the years 2015 through 2019 (the &#8220;Final Rule&#8221;). In the Final Rule, the EPA established a linear draw down for the production or importation of virgin HCFC-22 that started at approximately 22 million pounds in 2015 and was reduced by approximately 4.5 million pounds each year to end at zero in 2020.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">To the extent that the Company is unable to source sufficient quantities of refrigerants or is unable to obtain refrigerants on commercially reasonable terms or experiences a decline in demand and/or price for refrigerants sold by the Company, the Company could realize reductions in revenue from refrigerant sales, which could have a material adverse effect on its operating results and its financial position.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company is subject to various legal proceedings. The Company assesses the merit and potential liability associated with each of these proceedings. In addition, the Company estimates potential liability, if any, related to these matters. To the extent that these estimates are not accurate, or circumstances change in the future, the Company could realize liabilities, which could have a material adverse effect on its operating results and its financial position.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2018Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1050000 USD
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3052000 USD
CY2018Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3874000 USD
CY2017Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
15221000 USD
CY2018Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
19378000 USD
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
42403140 shares
CY2017Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
10885000 USD
CY2018Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
10774000 USD
CY2017Q4 us-gaap Assets
Assets
321444000 USD
CY2018Q2 us-gaap Assets
Assets
281010000 USD
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
184000 USD
CY2018Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
176000 USD
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
32419000 USD
CY2018Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
30936000 USD
CY2018Q2 us-gaap Goodwill
Goodwill
47803000 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
321444000 USD
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
281010000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
123453000 USD
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
90010000 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
8727000 USD
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-24945000 USD
CY2018Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
114531000 USD
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42403140 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42398140 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
42398140 shares
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Credit Risk</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of temporary cash investments and trade accounts receivable. The Company maintains its temporary cash investments in a highly-rated financial institution and, at times, the balances exceed FDIC insurance coverage. The Company&#8217;s trade accounts receivable are primarily due from companies throughout the United States. The Company reviews each customer&#8217;s credit history before extending credit.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company establishes an allowance for doubtful accounts based on factors associated with the credit risk of specific accounts, historical trends, and other information. The carrying value of the Company&#8217;s accounts receivable is reduced by the established allowance for doubtful accounts. The allowance for doubtful accounts includes any accounts receivable balances that are determined to be uncollectible, along with a general reserve for the remaining accounts receivable balances. The Company adjusts its reserves based on factors that affect the collectability of the accounts receivable balances.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">For the six month period ended June 30, 2018,&#160;</div>there were&#160;no&#160;<div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">customers that&#160;accounted for 10% or more of the Company&#8217;s </div>revenues.</div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">For the six month period ended June 30, 2017, two customers each accounted for 10% or more of the Company&#8217;s revenues and, in the aggregate these two customers accounted for 41% of the Company&#8217;s revenues. At June 30, 2017, there were $6.5 million in outstanding receivables from these customers.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The loss of a principal customer or a decline in the economic prospects of and/or a reduction in purchases of the Company&#8217;s products or services by any such customer could have a material adverse effect on the Company&#8217;s operating results and financial position.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43550226 shares
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42403140 shares
CY2017Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1982378 shares
CY2018Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41567848 shares
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42403140 shares
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
8525000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-30616000 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43490914 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42403084 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1953020 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41537894 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42403084 shares
CY2017Q4 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
1400000 USD
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
hdsn Operating Loss Carry Forwards Expirations Date
OperatingLossCarryForwardsExpirationsDate
2021
CY2017Q4 us-gaap Payables To Customers
PayablesToCustomers
9800000 USD
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
1991-01-11
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.72
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.72
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5314000 USD
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-10158000 USD
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
13839000 USD
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-40774000 USD
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
13900000 USD
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-37428000 USD
CY2017Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3399000 USD
CY2018Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10605000 USD
CY2017Q2 us-gaap Gross Profit
GrossProfit
17420000 USD
CY2018Q2 us-gaap Gross Profit
GrossProfit
-26082000 USD
CY2017Q2 us-gaap Revenues
Revenues
52231000 USD
CY2018Q2 us-gaap Revenues
Revenues
57831000 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.79
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.34
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.79
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8888000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-11222000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
23147000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-44894000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
23293000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-38342000 USD
us-gaap Operating Expenses
OperatingExpenses
6594000 USD
us-gaap Operating Expenses
OperatingExpenses
20165000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
243000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
1483000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6351000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
18682000 USD
us-gaap Gross Profit
GrossProfit
29887000 USD
us-gaap Gross Profit
GrossProfit
-18177000 USD
us-gaap Revenues
Revenues
91061000 USD
us-gaap Revenues
Revenues
100259000 USD
hdsn Production And Importation Permission Description
ProductionAndImportationPermissionDescription
22 million pounds in 2015 and was reduced by approximately 4.5 million pounds each year to end at zero in 2020.
CY2018Q2 us-gaap Payables To Customers
PayablesToCustomers
11300000 USD
CY2018Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
5400000 USD
CY2018Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
785697 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
785697 shares
CY2017Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Concentration Risk Customer
ConcentrationRiskCustomer
no customers each accounted for 10% or more of the Company&#8217;s revenues
us-gaap Concentration Risk Customer
ConcentrationRiskCustomer
two customers each accounted for 10% or more of the Company&#8217;s revenues
CY2018Q2 us-gaap Interest Expense
InterestExpense
3346000 USD
CY2017Q2 us-gaap Interest Expense
InterestExpense
61000 USD
us-gaap Interest Expense
InterestExpense
6552000 USD
us-gaap Interest Expense
InterestExpense
146000 USD
us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
2.8 million of which are subject to annual limitations of approximately $1.3 million.
CY2018Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
50205000 USD
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
49714000 USD
CY2018Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
21042000 USD
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19253000 USD
us-gaap Depreciation
Depreciation
2100000 USD
us-gaap Depreciation
Depreciation
1000000 USD
CY2017Q4 us-gaap Inventory Net
InventoryNet
172485000 USD
CY2018Q2 us-gaap Inventory Net
InventoryNet
116448000 USD
us-gaap Interest Paid Net
InterestPaidNet
142000 USD
us-gaap Interest Paid Net
InterestPaidNet
6107000 USD
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33673000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33931000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-258000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2668000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-328000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10615000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
155000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
562000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
0 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-10070000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
355000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
17000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
528000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-637000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-782000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
637000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
782000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
707000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8729000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4143000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4867000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1833000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
5827000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5529000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3583000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3988000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-24272000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
19785000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
23142000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
496000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-10729000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
33000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
485000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
214000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
60000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
35000 USD
us-gaap Inventory Write Down
InventoryWriteDown
0 USD
us-gaap Inventory Write Down
InventoryWriteDown
2520000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
243000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1483000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
966000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2080000 USD
us-gaap Net Income Loss
NetIncomeLoss
14259000 USD
us-gaap Net Income Loss
NetIncomeLoss
-33672000 USD
CY2018Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
34913000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
34913000 USD
CY2018Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3977000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2494000 USD
CY2018Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
30936000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
32419000 USD
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
10000000 shares
CY2018Q2 us-gaap Deferred Compensation Arrangement With Individual Common Stock Reserved For Future Issuance
DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance
8537873 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
231500 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
666697 shares
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
400000 USD
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
5500000 USD
CY2018Q2 hdsn Sharebased Compensation Arrangement By Sharebased Payment Award Options Aggregate Intrinsic Value Nonvested
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAggregateIntrinsicValueNonvested
0 USD
CY2017Q4 hdsn Sharebased Compensation Arrangement By Sharebased Payment Award Options Aggregate Intrinsic Value Nonvested
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAggregateIntrinsicValueNonvested
0 USD
CY2018Q2 hdsn Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable And Vested Intrinsic Value1
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableAndVestedIntrinsicValue1
0 USD
CY2017Q2 hdsn Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable And Vested Intrinsic Value1
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableAndVestedIntrinsicValue1
900000 USD
CY2018Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
55082000 USD
CY2017Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
65152000 USD
CY2018Q2 hdsn Longterm Debt Current Net Of Other Debt
LongtermDebtCurrentNetOfOtherDebt
1050000 USD
CY2017Q4 hdsn Longterm Debt Current Net Of Other Debt
LongtermDebtCurrentNetOfOtherDebt
1050000 USD
CY2018Q2 us-gaap Debt Current
DebtCurrent
56132000 USD
CY2017Q4 us-gaap Debt Current
DebtCurrent
66202000 USD
CY2018Q2 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
103425000 USD
CY2017Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
103950000 USD
CY2018Q2 hdsn Vehicle And Equipment Loans
VehicleAndEquipmentLoans
12000 USD
CY2017Q4 hdsn Vehicle And Equipment Loans
VehicleAndEquipmentLoans
39000 USD
CY2018Q2 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
12000 USD
CY2017Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
20000 USD
CY2018Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
2607000 USD
CY2017Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
2851000 USD
CY2018Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
100842000 USD
CY2017Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
101158000 USD
CY2018Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
156974000 USD
CY2017Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
167360000 USD
CY2018Q2 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
100000 USD
CY2018Q2 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
70000 USD
CY2018Q2 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
6000 USD
CY2018Q2 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
6000 USD
CY2018Q2 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
0 USD
CY2018Q2 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
0 USD
CY2018Q2 hdsn Capital Lease Obligations Repayments Due
CapitalLeaseObligationsRepaymentsDue
82000 USD
CY2018Q2 hdsn Capital Lease Obligations Repayments Interest Included In Payments
CapitalLeaseObligationsRepaymentsInterestIncludedInPayments
3000 USD
CY2018Q2 us-gaap Capital Leases Future Minimum Payments Net Minimum Payments1
CapitalLeasesFutureMinimumPaymentsNetMinimumPayments1
79000 USD
CY2018Q2 us-gaap Long Term Debt And Capital Lease Obligations Repayments Of Principal In Next Twelve Months
LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths
1657000 USD
CY2018Q2 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo
2118000 USD
CY2018Q2 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree
2106000 USD
CY2018Q2 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour
2100000 USD
CY2018Q2 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Five
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive
2100000 USD
CY2018Q2 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal After Year Five
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive
94500000 USD
CY2018Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
104581000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P2Y3M18D
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1.56
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
200000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 USD
CY2017Q1 hdsn Earnings Before Interest Tax Depreciation And Amortization
EarningsBeforeInterestTaxDepreciationAndAmortization
21900000 USD
CY2017Q2 hdsn Earnings Before Interest Tax Depreciation And Amortization
EarningsBeforeInterestTaxDepreciationAndAmortization
26100000 USD
CY2017Q4 us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
209000000 USD
CY2018Q2 us-gaap Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
46900000 USD
hdsn Fixed Charge Coverage Ratio Requirement
FixedChargeCoverageRatioRequirement
1.00 to 1.00
CY2018Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
9255000 USD
CY2017Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
0 USD
hdsn Ratios Of Indebtedness To Net Capital Requirement
RatiosOfIndebtednessToNetCapitalRequirement
4.75 to 1.00
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-6321000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
6559000 USD
hdsn Lower Of Cost Or Net Realizable Value Adjustment
LowerOfCostOrNetRealizableValueAdjustment
30906000 USD
hdsn Lower Of Cost Or Net Realizable Value Adjustment
LowerOfCostOrNetRealizableValueAdjustment
0 USD
CY2018Q2 hdsn Lower Of Cost Or Net Realizable Value Adjustment
LowerOfCostOrNetRealizableValueAdjustment
34700000 USD
CY2018Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
57831000 USD
CY2017Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
52231000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
100259000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
91061000 USD
CY2018Q2 hdsn Cost Of Sales Excluding Cost Of Net Realizable Value Adjustment
CostOfSalesExcludingCostOfNetRealizableValueAdjustment
83913000 USD
CY2017Q2 hdsn Cost Of Sales Excluding Cost Of Net Realizable Value Adjustment
CostOfSalesExcludingCostOfNetRealizableValueAdjustment
34811000 USD
hdsn Cost Of Sales Excluding Cost Of Net Realizable Value Adjustment
CostOfSalesExcludingCostOfNetRealizableValueAdjustment
118436000 USD
hdsn Cost Of Sales Excluding Cost Of Net Realizable Value Adjustment
CostOfSalesExcludingCostOfNetRealizableValueAdjustment
61174000 USD
CY2018Q2 hdsn Lower Of Cost Or Net Realizable Value Adjustment Gross
LowerOfCostOrNetRealizableValueAdjustmentGross
17100000 USD
CY2018Q2 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
48600000 USD
CY2016Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
112017000 USD
CY2017 hdsn Stock Issued During Period Value Stock Options And Warrants Exercised
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised
807000 USD
CY2017 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2026000 USD
CY2017 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
47000 USD
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1451000 USD
CY2017 us-gaap Net Income Loss
NetIncomeLoss
11157000 USD
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
123453000 USD
hdsn Stock Issued During Period Value Stock Options And Warrants Exercised
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised
17000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
212000 USD
CY2018Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
90010000 USD

Files In Submission

Name View Source Status
0001144204-18-062664-index-headers.html Edgar Link pending
0001144204-18-062664-index.html Edgar Link pending
0001144204-18-062664.txt Edgar Link pending
0001144204-18-062664-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hdsn-20180630.xml Edgar Link completed
hdsn-20180630.xsd Edgar Link pending
hdsn-20180630_cal.xml Edgar Link unprocessable
hdsn-20180630_def.xml Edgar Link unprocessable
hdsn-20180630_lab.xml Edgar Link unprocessable
hdsn-20180630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tv500288_10q.htm Edgar Link pending
tv500288_ex10-1.htm Edgar Link pending
tv500288_ex10-2.htm Edgar Link pending
tv500288_ex10-3.htm Edgar Link pending
tv500288_ex31-1.htm Edgar Link pending
tv500288_ex31-2.htm Edgar Link pending
tv500288_ex32-1.htm Edgar Link pending
tv500288_ex32-2.htm Edgar Link pending